INTEGRATED BIOPHARMA INC Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
INTEGRATED BIOPHARMA INC (INBP) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.33 per share for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-05-08
- INTEGRATED BIOPHARMA INC share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-09-30 was $0.19, a 42.42% decline year-over-year.
- INTEGRATED BIOPHARMA INC share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-09-30 was $0.33.
- INTEGRATED BIOPHARMA INC share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $0.29, a 7.41% increase from fiscal 2024.
- INTEGRATED BIOPHARMA INC share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $0.27, a 35.71% decline from fiscal 2023.
- INTEGRATED BIOPHARMA INC share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $0.42, a 50.59% decline from fiscal 2022.
- INTEGRATED BIOPHARMA INC share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $0.85, a 28.79% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.33 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | $0.33 10-Q · filed 2026-02-11 | |||
| 2025-06-30 | $0.29 10-K · filed 2025-09-23 | |||
| 2025-03-31 | $0.28 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | $0.28 10-Q · filed 2025-02-13 | |||
| 2024-09-30 | $0.19 10-Q · filed 2024-11-13 | |||
| 2024-06-30 | $0.27 10-K · filed 2025-09-23 | |||
| 2024-03-31 | $0.27 10-Q · filed 2024-05-10 | |||
| 2023-12-31 | $0.27 10-Q · filed 2024-02-12 | |||
| 2023-09-30 | $0.33 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | $0.42 10-K · filed 2024-09-20 | |||
| 2023-03-31 | $0.42 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $0.42 10-Q · filed 2023-02-10 | |||
| 2022-06-30 | $0.85 10-K · filed 2023-09-15 | |||
| 2022-03-31 | $0.97 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $0.97 10-Q · filed 2022-02-10 | |||
| 2021-06-30 | $0.66 10-K · filed 2022-09-13 | |||
| 2019-06-30 | $0.21 10-K · filed 2020-09-23 | |||
| 2017-06-30 | $0.24 10-K · filed 2018-09-12 | |||
| 2016-06-30 | $0.00 10-K · filed 2016-09-02 | |||
| 2015-06-30 | $0.09 10-K · filed 2016-09-02 | |||
| 2014-06-30 | $0.14 10-K · filed 2014-09-08 | |||
| 2013-06-30 | $0.00 10-K · filed 2013-09-30 | |||
| 2012-06-30 | $0.00 10-K · filed 2013-09-30 | |||
| 2011-06-30 | $0.00 10-K · filed 2012-10-15 |